TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes.
Nakagawa Y, Shimano H, Yoshikawa T, Ide T, Tamura M, Furusawa M, Yamamoto T, Inoue N, Matsuzaka T, Takahashi A, Hasty AH, Suzuki H, Sone H, Toyoshima H, Yahagi N, Yamada N.
Nakagawa Y, et al. Among authors: shimano h.
Nat Med. 2006 Jan;12(1):107-13. doi: 10.1038/nm1334. Epub 2005 Dec 4.
Nat Med. 2006.
PMID: 16327801